The HCPLive Vitiligo condition center page is a comprehensive resource for clinical news and insights on the dermatologic condition. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for the affected skin of vitiligo patients.
February 1st 2024
These data highlight the severe economic burden faced by patients with vitiligo compared to that of the general population, including mental health-related costs.
Greater Guselkumab Response More Likely Among Younger, Less Obese Psoriasis Patients
A post-hoc analysis of clinical trial data found that psoriasis patients who were younger, less obese and had less severe psoriasis were more likely to achieve super-response to biologic treatment with guselkumab.
Biologic Agents May Reduce Risk of Mental Health Disorders in Some Patients with Psoriasis
Biologic agents may reduce the risk of mental health disorders among patients with moderate-to-severe psoriasis who discontinued treatment with conventional systemic agents, researchers in Canada found.
Investigators Highlight Unmet Needs of Patients with Generalized Pustular Psoriasis
August 15th 2022Among flares identified in outpatient (53%), inpatient (36%), and emergency department (9%) settings, the most utilized treatments were topical corticosteroids (35%), opioids (21%), and other oral treatments.
Half of Health Care Providers Report Acne During COVID-19 Pandemic
The COVID-19 pandemic has drawn attention to acne associated with the prolonged use of medical face masks and raised awareness about the need for adequate screening, training and treatment of the condition.